The mission of TeloMe (pronounced "tella-me") is to bring affordable biomarker testing to everyone, with a particular focus on telomere length, which has emerged as potentially the single most powerful and modifiable predictor of current and future health. However, current technologies have many limitations and produced some contradictory and questionable results. For maximum affordability and accessibility, we have focused on saliva-based testing, and direct sample collection by mail and courier. TeloMe's suite of technologies provides accurate and reproducible measurement of telomere length in saliva or blood, allowing non-invasive and convenient collection of samples through the mail and in the clinic.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2010
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was TeloMe founded?
TeloMe was founded in 2010.
What industry is TeloMe in?
TeloMe operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Find investors for your startup like TeloMe
Gritt sends AI-personalised outreach to each investor — from your Gmail
